Specialty Chemicals company Camlin Fine Sciences announced Q1FY26 results Revenue: Rs 4,236 million compared to Rs Rs 3,809 million during Q1FY25. EBITDA: Rs 190 million compared to Rs Rs 392 million during Q1FY25. EBITDA Margin: 4.49% for Q1FY26. PAT: Rs -43 million compared to Rs Rs -182 million during Q1FY25. Result PDF
Conference Call with Camlin Fine Sciences Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.